Corey Strickland - Proteovant Therapeut

基本信息

浏览量：3

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 154 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Discovery of Oral SMARCA2 Degraders for the Treatment of SMARCA4 Mutant Tumors

Jose C. Clemente, Lal Harikrishnan, Steve Knight, Debangshu Samanta, Zhenwu Li, Rakesh Nagilla, Nathan Kendsersky, Shreyas Joshi,Peter Orth, Matt Tudor,Qiaolin Deng, Clemente Aguilar-Bonavides, Elham Behshad, Zhihua Sui,Corey Strickland, Larry J. Jolivette, Helai P. Mohammad

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Abstract 6043: Discovery and characterization of a p300-selective degrader with potent anti-tumor activity in CBP mutant cancers

Mike R. Russell, Cassandra L. Lowenstein, Xuqing Zhang, Jeremy Roach, Jianing Song,Rakesh Nagilla,Nathan Kendsersky, Shreyas Joshi,Peter Orth, Matt Tudor, Qiaolin Deng,Clemente Aguilar-Bonavides,Elham Behshad, Sudeep Banjade,Zhihua Sui,Corey Strickland, Larry Jolivette,Helai P. Mohammad

Cancer Researchno. 6_Supplement (2024): 6043-6043

引用0浏览0引用

Discovery and Characterization of a P300-Selective Degrader with Potent Anti-Tumor Activity in CBP Mutant Cancers

Mike R. Russell, Cassandra L. Lowenstein, Xuqing Zhang, Jeremy Roach, Jianing Song, Rakesh Nagilla, Nathan Kendsersky, Shreyas Joshi,Peter Orth, Matt Tudor,Qiaolin Deng, Clemente Aguilar-Bonavides, Elham Behshad, Sudeep Banjade, Zhihua Sui,Corey Strickland, Larry Jolivette, Helai P. Mohammad

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Abstract 6051: Discovery of Oral SMARCA2 Degraders for the Treatment of SMARCA4 Mutant Tumors